跳至主要内容
临床试验/RBR-10t3wc7z
RBR-10t3wc7z尚未招募不适用

Accuracy of a flexible nanodevice based on DNA probes and conductive polymers for ultrasensitive diagnosis of chimeric oncogenes associated with childhood Lymphocytic Leukemia in health units in Brazil and therapeutic decision under the Brazilian Childhood Leukemia Treatment Group (GBTLI) protocol - 2020

Instituto Aggeu Magalhães - Fiocruz de Pernambuco0 个研究点开始时间: 2023年8月18日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
0 至 20Y(—)

入选标准

  • Patients with a maximum age of 20 years; both genders; attended at reference services for the treatment of leukemia in Brazil with a clinical and cytological diagnosis of leucemia; who express the desire to participate in the project and the legal guardians sign the Free and Informed Consent Form and the children between 8 and 18 years old sign the Free and Informed Assent Term, providing clinical information, and allowing the analysis of samples (bone marrow) in the laboratory reference of the study in Recife

排除标准

  • Patients with mature B-cell Leukaemia

研究者

发起方
Instituto Aggeu Magalhães - Fiocruz de Pernambuco

相似试验